Palisade Bio, Inc. Common Stock
Symbol: PALI (NASDAQ)
0.60
▼ (-4.54%) -0.029
Company Description:
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
Key Stats
- Today's Open: $0.6362
- Today's High: $0.752
- Today's Low: $0.597
- Today's Volume: 5.05M
- Yesterday Close: $0.6327
- Yesterday High: $0.6572
- Yesterday Low: $0.62
- Yesterday Volume: 256.93K
- Last Min Volume: 100
- Last Min High: $0.604
- Last Min Low: $0.604
- Last Min VWAP: $0.604
Company Profile
- Name: Palisade Bio, Inc. Common Stock
- Website: https://www.palisadebio.com
- Listed Date: 2021-04-28
- Location: CARLSBAD, CA
- Market Status: Active
- CIK Number: 0001357459
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $5.84M
- Round Lot: 100
- Outstanding Shares: 9.32M
- Asset Type: CS
RECENT FILINGS FOR PALI
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-05 | PRE 14A | View |
| 2025-09-05 | 8-K | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-08-28 | EFFECT | View |
| 2025-08-18 | DEF 14A | View |
| 2025-08-15 | S-3 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-06 | PRE 14A | View |
| 2025-07-25 | 8-K | View |
| 2025-07-22 | 4 | View |
| 2025-07-17 | 3 | View |
| 2025-07-09 | 8-K | View |
| 2025-06-12 | RW | View |
| 2025-05-27 | S-1 | View |
| 2025-05-15 | SCHEDULE 13G/A | View |
Latest News on PALI